After Finra warning, firms back away from leveraged ETFs

At least three brokerage firms have decided not to sell leveraged exchange traded funds a month after the Financial Industry Regulatory Authority Inc. warned brokers that they “typically are unsuitable for retail investors” who hold them longer than a day.
JUL 24, 2009
At least three brokerage firms have decided not to sell leveraged exchange traded funds a month after the Financial Industry Regulatory Authority Inc. warned brokers that they “typically are unsuitable for retail investors” who hold them longer than a day. The New York- and Washington-based regulator clarified its position on such ETFs in a podcast July 13, saying Finra member firms could recommend that a retail investor hold such ETFs for longer than one day provided that a suitability assessment is conducted with respect to the investor and the ETF. But that didn't stop Edward D. Jones & Co. LP of St. Louis, Ameriprise Financial Inc. of Minneapolis, and LPL Investment Holdings Inc. of Boston, from banning the sale of such ETFs within the last few weeks. In LPL's case, the company decided to prohibit the sale of leveraged ETFs that seek more than two times the long or short performance of the target index, said spokesman Joseph Kuo. Direxion Funds of Newton, Mass., one of the major players in the leveraged ETF and mutual fund arena, is reaching out to the brokerage firms to argue that the funds can be used successfully, said Andy O'Rourke, the firm's marketing director. Special attention, however, is being paid LPL because Direxion believes that firm's registered representatives are best suited to use its ETFs, he said. “We're talking about what the rationale is behind their decision, and if there is anything we can do to get them to open up [access to leveraged ETFs] to a limited audience,” Mr. O'Rourke said.

Latest News

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor